Sbi Securities Co., Ltd. Prelude Therapeutics Inc Transaction History
Sbi Securities Co., Ltd.
- $3.48 Trillion
- Q2 2025
A detailed history of Sbi Securities Co., Ltd. transactions in Prelude Therapeutics Inc stock. As of the latest transaction made, Sbi Securities Co., Ltd. holds 2,741 shares of PRLD stock, worth $2,302. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,741
Previous 2,741
-0.0%
Holding current value
$2,302
Previous $2.11 Million
5.42%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding PRLD
# of Institutions
51Shares Held
27.7MCall Options Held
23.9KPut Options Held
0-
Orbimed Advisors LLC San Diego, CA10.9MShares$9.16 Million0.26% of portfolio
-
Baker Bros. Advisors LP New York, NY10.1MShares$8.5 Million0.09% of portfolio
-
Black Rock Inc. New York, NY1.07MShares$897,8890.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD976KShares$819,9630.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA933KShares$783,3580.0% of portfolio
About Prelude Therapeutics Inc
- Ticker PRLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,369,200
- Market Cap $30.6M
- Description
- Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT543 that is in Phase 1 clinical trials in select solid tumors and myeloid malignancies; and PRT811, which is in Phase 1 clinical trials in solid ...